Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AdvaMed Principles For Artificial Intelligence Focus On Patient, Physician Needs

Executive Summary

AdvaMed’s principles for artificial intelligence development focus on using the technology to meet patient needs.

You may also be interested in...



Leading Medical Imaging Companies Leave MITA, Join AdvaMed

Six of the largest medical imaging companies left the Medical Imaging Trade Association to join AdvaMed, which just announced a new medical imaging division.

AMA Establishes Principles For ‘Augmented Intelligence’

The American Medical Association has written a set of principles for augmented intelligence (AI) development and deployment in health care. The organization hopes these principles can shape “a consistent governance structure for advancements in health care technology.”

FDA Publishes 5 PCCP Principles For ML Devices In Collaboration With Canada And UK

Five guiding principles for PCCPs for ML devices exemplify international harmonization efforts from regulators.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT154455

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel